Astrana Health (NASDAQ:ASTH - Get Free Report) is expected to post its quarterly earnings results before the market opens on Tuesday, February 25th. Analysts expect Astrana Health to post earnings of $0.22 per share and revenue of $617.24 million for the quarter. Individual interested in registering for the company's earnings conference call can do so using this link.
Astrana Health Stock Down 4.6 %
Shares of NASDAQ:ASTH traded down $1.71 during trading on Friday, hitting $35.68. The company's stock had a trading volume of 291,742 shares, compared to its average volume of 336,834. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.91 and a current ratio of 1.91. Astrana Health has a fifty-two week low of $29.08 and a fifty-two week high of $63.20. The stock's 50-day moving average price is $35.06 and its two-hundred day moving average price is $44.99. The company has a market capitalization of $2.01 billion, a PE ratio of 27.45, a PEG ratio of 1.51 and a beta of 1.20.
Analyst Upgrades and Downgrades
ASTH has been the subject of several research analyst reports. Macquarie raised Astrana Health to a "hold" rating in a report on Monday, December 16th. Truist Financial lowered their price objective on Astrana Health from $59.00 to $50.00 and set a "buy" rating for the company in a report on Monday, January 13th. Robert W. Baird boosted their price objective on Astrana Health from $67.00 to $86.00 and gave the company an "outperform" rating in a report on Wednesday, November 13th. Finally, Stifel Nicolaus lowered their price objective on Astrana Health from $70.00 to $56.00 and set a "buy" rating for the company in a report on Thursday. Two research analysts have rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $63.00.
Check Out Our Latest Stock Report on ASTH
About Astrana Health
(
Get Free Report)
Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.
See Also
Before you consider Astrana Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astrana Health wasn't on the list.
While Astrana Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
